JOSÉ IGNACIO
ARAMENDI GALLARDO
Forscher bis um 2023
Hospital Clinic Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Clinic Barcelona (9)
2019
-
Mitral valve repair in infective endocarditis is not inferior to valve replacement: results from a Spanish nationwide prospective registry
General Thoracic and Cardiovascular Surgery, Vol. 67, Núm. 7, pp. 585-593
-
Role of age and comorbidities in mortality of patients with infective endocarditis
European Journal of Internal Medicine, Vol. 64, pp. 63-71
2016
-
Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)
American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584
2014
-
Initial experience with rivaroxaban in mechanical valve prosthesis in an animal model
European Journal of Cardio-thoracic Surgery
-
Validación de EuroSCORE II en España
Cirugia Cardiovascular, Vol. 21, Núm. 4, pp. 246-251
2013
-
In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011
Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958
2008
-
Antithrombotic therapy after bioprosthetic aortic valve replacement
European Journal of Cardio-thoracic Surgery
2005
-
Erratum: Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): Prospective, randomized, co-operative trial (European Journal of Cardio-thoracic Surgery (2005) 27 (854-860) PII: S1010794005001284 and DOI: 10.1016/j.ejcts.2004.12.064)
European Journal of Cardio-thoracic Surgery
-
Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): Prospective, randomized, co-operative trial
European Journal of Cardio-thoracic Surgery